These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15586316)

  • 81. Management of antipsychotic-related weight gain.
    Maayan L; Correll CU
    Expert Rev Neurother; 2010 Jul; 10(7):1175-200. PubMed ID: 20586697
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Short-term treatment of obesity: comparison between anorexigens and behavior modification].
    Hernández A; de los Angeles Saavedra M
    Rev Med Chil; 1984 Feb; 112(2):132-8. PubMed ID: 6740020
    [No Abstract]   [Full Text] [Related]  

  • 83. Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia.
    Marteene W; Winckel K; Hollingworth S; Kisely S; Gallagher E; Hahn M; Ebdrup BH; Firth J; Siskind D
    Expert Opin Drug Saf; 2019 Dec; 18(12):1149-1160. PubMed ID: 31564170
    [No Abstract]   [Full Text] [Related]  

  • 84. Evaluation and treatment of obesity.
    Azar ST; Zantout MS
    J Med Liban; 2000; 48(5):310-4. PubMed ID: 12489585
    [No Abstract]   [Full Text] [Related]  

  • 85. Psychotropic drug-induced weight gain alleviated with orlistat: a case series.
    Schwartz TL; Beale M
    Psychopharmacol Bull; 2003; 37(1):5-9. PubMed ID: 14561945
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comment: Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
    Hahn MK; Cohn T; Remington G
    Ann Pharmacother; 2010; 44(7-8):1349-50; author reply 1350-1. PubMed ID: 20587740
    [No Abstract]   [Full Text] [Related]  

  • 87. Weight gain associated with neuroleptic medication: a review.
    Stanton JM
    Schizophr Bull; 1995; 21(3):463-72. PubMed ID: 7481576
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Therapies for obesity and medication-associated weight gain.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2013 May; 51(5):13-6. PubMed ID: 23590816
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Antipsychotic drugs: the weight problem.
    Harv Ment Health Lett; 2000 Dec; 17(6):6-8. PubMed ID: 11114878
    [No Abstract]   [Full Text] [Related]  

  • 90. Metformin provides weight reduction for hospitalized patients receiving polypharmacy.
    Winsberg B; Yeager C; Hobbs B; Wei R; Elangovan N
    J Clin Psychopharmacol; 2010 Jun; 30(3):345-6. PubMed ID: 20473081
    [No Abstract]   [Full Text] [Related]  

  • 91. Nutritional approach to metabolic changes arising out of schizophrenia therapy: case report.
    Ozenoglu A; Ugurlu S; Balci H; Eker E
    Intern Med; 2007; 46(15):1213-8. PubMed ID: 17675772
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Is acetazolamide similar to topiramate for reversal of antipsychotic-induced weight gain?
    Schneiderhan ME; Marvin R
    Am J Ther; 2007; 14(6):581-4. PubMed ID: 18090883
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Weight Gain Risk Factor assessment checklist: overview and recommendation for use.
    Treuer T; Pendlebury J; Lockman H; Bushe C; Karagianis J; Raskin J; Lipkovich I
    Neuro Endocrinol Lett; 2011; 32(2):199-205. PubMed ID: 21552187
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Circuits controlling energy balance and mood: inherently intertwined or just complicated intersections?
    Liu C; Lee S; Elmquist JK
    Cell Metab; 2014 Jun; 19(6):902-9. PubMed ID: 24630814
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis.
    Maayan L; Vakhrusheva J; Correll CU
    Neuropsychopharmacology; 2010 Jun; 35(7):1520-30. PubMed ID: 20336059
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Conservative therapy of obesity].
    Wechsler JG
    Zentralbl Chir; 1996; 121(5):358-62. PubMed ID: 8677695
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Eating-behavior changes associated with antipsychotic medications in patients with schizophrenia as measured by the drug-related eating behavior questionnaire.
    Ryu S; Nam HJ; Oh S; Park T; Lim M; Choi JS; Baek JH; Jang JH; Park HY; Kim SN; Joo YH; Kwon JS; Hong KS
    J Clin Psychopharmacol; 2013 Feb; 33(1):120-2. PubMed ID: 23277254
    [No Abstract]   [Full Text] [Related]  

  • 98. [Obesity: a multifactorial disorder with difficult long-term treatment].
    Cotrozzi G; Relli P; Fontana R
    Clin Ter; 1994 Nov; 145(11):353-68. PubMed ID: 7889721
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials.
    Alvarez-Jiménez M; Hetrick SE; González-Blanch C; Gleeson JF; McGorry PD
    Br J Psychiatry; 2008 Aug; 193(2):101-7. PubMed ID: 18669990
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Drug induced weight gain, an impediment to successful pharmacotherapy: focus on antipsychotics.
    Baptista T; Zárate J; Joober R; Colasante C; Beaulieu S; Páez X; Hernández L
    Curr Drug Targets; 2004 Apr; 5(3):279-99. PubMed ID: 15058313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.